Aura Biosciences Inc (AURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -86,919 | -61,085 | -40,043 | -19,706 | -76,408 |
| Depreciation Amortization | 1,223 | 932 | 619 | 306 | 1,295 |
| Accounts payable and accrued liabilities | 482 | 172 | -517 | 23 | -1,040 |
| Other Working Capital | -2,642 | -1,700 | -5,078 | -6,803 | 4,441 |
| Other Operating Activity | 8,051 | 5,828 | 4,439 | 1,728 | 7,865 |
| Operating Cash Flow | $-79,805 | $-55,853 | $-40,580 | $-24,452 | $-63,847 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 70,074 | 40,080 | 29,850 | 9,484 | -113,254 |
| PPE Investments | -1,253 | -954 | -613 | -88 | -709 |
| Investing Cash Flow | $68,821 | $39,126 | $29,237 | $9,396 | $-113,963 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,595 | 1,052 | 336 | 253 | 97,290 |
| Financing Cash Flow | $1,595 | $1,052 | $336 | $253 | $97,290 |
| Beginning Cash Position | 41,850 | 41,850 | 41,850 | 41,850 | 122,370 |
| End Cash Position | 32,461 | 26,175 | 30,843 | 27,047 | 41,850 |
| Net Cash Flow | $-9,389 | $-15,675 | $-11,007 | $-14,803 | $-80,520 |
| Free Cash Flow | |||||
| Operating Cash Flow | -79,805 | -55,853 | -40,580 | -24,452 | -63,847 |
| Capital Expenditure | -1,253 | -954 | -613 | -88 | -709 |
| Free Cash Flow | -81,058 | -56,807 | -41,193 | -24,540 | -64,556 |